These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26077951)

  • 1. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
    Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
    Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.
    Allen M; Burgess JD; Ballard T; Serie D; Wang X; Younkin CS; Sun Z; Kouri N; Baheti S; Wang C; Carrasquillo MM; Nguyen T; Lincoln S; Malphrus K; Murray M; Golde TE; Price ND; Younkin SG; Schellenberg GD; Asmann Y; Ordog T; Crook J; Dickson D; Ertekin-Taner N
    Acta Neuropathol; 2016 Aug; 132(2):197-211. PubMed ID: 27115769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent trait modeling of tau neuropathology in progressive supranuclear palsy.
    Kouri N; Murray ME; Reddy JS; Serie DJ; Soto-Beasley A; Allen M; Carrasquillo MM; Wang X; Castanedes MC; Baker MC; Rademakers R; Uitti RJ; Graff-Radford NR; Wszolek ZK; Schellenberg GD; Crook JE; Ertekin-Taner N; Ross OA; Dickson DW
    Acta Neuropathol; 2021 May; 141(5):667-680. PubMed ID: 33635380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
    Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
    Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
    Yokoyama JS; Karch CM; Fan CC; Bonham LW; Kouri N; Ross OA; Rademakers R; Kim J; Wang Y; Höglinger GU; Müller U; Ferrari R; Hardy J; ; Momeni P; Sugrue LP; Hess CP; James Barkovich A; Boxer AL; Seeley WW; Rabinovici GD; Rosen HJ; Miller BL; Schmansky NJ; Fischl B; Hyman BT; Dickson DW; Schellenberg GD; Andreassen OA; Dale AM; Desikan RS
    Acta Neuropathol; 2017 May; 133(5):825-837. PubMed ID: 28271184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
    Chen Z; Chen JA; Shatunov A; Jones AR; Kravitz SN; Huang AY; Lawrence L; Lowe JK; Lewis CM; Payan CAM; Lieb W; Franke A; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; ; Ludolph A; Bensimon G; Leigh PN; Bronstein JM; Coppola G; Geschwind DH; Al-Chalabi A
    Mov Disord; 2019 Jul; 34(7):1049-1059. PubMed ID: 31059154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
    Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
    J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.
    Pastor P; Ezquerra M; Perez JC; Chakraverty S; Norton J; Racette BA; McKeel D; Perlmutter JS; Tolosa E; Goate AM
    Ann Neurol; 2004 Aug; 56(2):249-58. PubMed ID: 15293277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.
    Cruchaga C; Vidal-Taboada JM; Ezquerra M; Lorenzo E; Martinez-Lage P; Blazquez M; Tolosa E; ; Pastor P
    Neurobiol Dis; 2009 Feb; 33(2):164-70. PubMed ID: 19022385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.
    Valentino RR; Tamvaka N; Heckman MG; Johnson PW; Soto-Beasley AI; Walton RL; Koga S; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA
    Acta Neuropathol Commun; 2020 Sep; 8(1):162. PubMed ID: 32943110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.
    Farrell K; Humphrey J; Chang T; Zhao Y; Leung YY; Kuksa PP; Patil V; Lee WP; Kuzma AB; Valladares O; Cantwell LB; Wang H; Ravi A; De Sanctis C; Han N; Christie TD; Afzal R; Kandoi S; Whitney K; Krassner MM; Ressler H; Kim S; Dangoor D; Iida MA; Casella A; Walker RH; Nirenberg MJ; Renton AE; Babrowicz B; Coppola G; Raj T; Höglinger GU; Müller U; Golbe LI; Morris HR; Hardy J; Revesz T; Warner TT; Jaunmuktane Z; Mok KY; Rademakers R; Dickson DW; Ross OA; Wang LS; Goate A; Schellenberg G; Geschwind DH; ; Crary JF; Naj A
    Nat Commun; 2024 Sep; 15(1):7880. PubMed ID: 39251599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
    Chen JA; Chen Z; Won H; Huang AY; Lowe JK; Wojta K; Yokoyama JS; Bensimon G; Leigh PN; Payan C; Shatunov A; Jones AR; Lewis CM; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; Ludolph A; Boxer AL; Bronstein JM; Al-Chalabi A; Geschwind DH; Coppola G
    Mol Neurodegener; 2018 Aug; 13(1):41. PubMed ID: 30089514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.
    Manzoni C; Kia DA; Ferrari R; Leonenko G; Costa B; Saba V; Jabbari E; Tan MM; Albani D; Alvarez V; Alvarez I; Andreassen OA; Angiolillo A; Arighi A; Baker M; Benussi L; Bessi V; Binetti G; Blackburn DJ; Boada M; Boeve BF; Borrego-Ecija S; Borroni B; Bråthen G; Brooks WS; Bruni AC; Caroppo P; Bandres-Ciga S; Clarimon J; Colao R; Cruchaga C; Danek A; de Boer SC; de Rojas I; di Costanzo A; Dickson DW; Diehl-Schmid J; Dobson-Stone C; Dols-Icardo O; Donizetti A; Dopper E; Durante E; Ferrari C; Forloni G; Frangipane F; Fratiglioni L; Kramberger MG; Galimberti D; Gallucci M; García-González P; Ghidoni R; Giaccone G; Graff C; Graff-Radford NR; Grafman J; Halliday GM; Hernandez DG; Hjermind LE; Hodges JR; Holloway G; Huey ED; Illán-Gala I; Josephs KA; Knopman DS; Kristiansen M; Kwok JB; Leber I; Leonard HL; Libri I; Lleo A; Mackenzie IR; Madhan GK; Maletta R; Marquié M; Maver A; Menendez-Gonzalez M; Milan G; Miller BL; Morris CM; Morris HR; Nacmias B; Newton J; Nielsen JE; Nilsson C; Novelli V; Padovani A; Pal S; Pasquier F; Pastor P; Perneczky R; Peterlin B; Petersen RC; Piguet O; Pijnenburg YA; Puca AA; Rademakers R; Rainero I; Reus LM; Richardson AM; Riemenschneider M; Rogaeva E; Rogelj B; Rollinson S; Rosen H; Rossi G; Rowe JB; Rubino E; Ruiz A; Salvi E; Sanchez-Valle R; Sando SB; Santillo AF; Saxon JA; Schlachetzki JC; Scholz SW; Seelaar H; Seeley WW; Serpente M; Sorbi S; Sordon S; St George-Hyslop P; Thompson JC; Van Broeckhoven C; Van Deerlin VM; Van der Lee SJ; Van Swieten J; Tagliavini F; van der Zee J; Veronesi A; Vitale E; Waldo ML; Yokoyama JS; Nalls MA; Momeni P; Singleton AB; Hardy J; Escott-Price V
    Am J Hum Genet; 2024 Jul; 111(7):1316-1329. PubMed ID: 38889728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants.
    Razquin C; Ortega-Cubero S; Rojo-Bustamante E; Diez-Fairen M; Lorenzo E; Alonso E; Ezquerra M; Ross OA; Carcel M; Lorenzo-Betancor O; Soto AI; Burgess JD; Ertekin-Taner N; Dickson DW; Pastor MA; Tolosa E; Pastor P
    Neurobiol Aging; 2018 Jun; 66():177.e7-177.e10. PubMed ID: 29398119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic influences on cognition in progressive supranuclear palsy.
    Gerstenecker A; Roberson ED; Schellenberg GD; Standaert DG; Shprecher DR; Kluger BM; Litvan I
    Mov Disord; 2017 Dec; 32(12):1764-1771. PubMed ID: 29076559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
    Kertesz A; Munoz D
    Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.
    Houlden H; Baker M; Morris HR; MacDonald N; Pickering-Brown S; Adamson J; Lees AJ; Rossor MN; Quinn NP; Kertesz A; Khan MN; Hardy J; Lantos PL; St George-Hyslop P; Munoz DG; Mann D; Lang AE; Bergeron C; Bigio EH; Litvan I; Bhatia KP; Dickson D; Wood NW; Hutton M
    Neurology; 2001 Jun; 56(12):1702-6. PubMed ID: 11425937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.
    Ferrari R; Ryten M; Simone R; Trabzuni D; Nicolaou N; Hondhamuni G; Ramasamy A; Vandrovcova J; ; Weale ME; Lees AJ; Momeni P; Hardy J; de Silva R
    Neurobiol Aging; 2014 Jun; 35(6):1514.e1-12. PubMed ID: 24503276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.
    Zhang CC; Zhu JX; Wan Y; Tan L; Wang HF; Yu JT; Tan L
    Oncotarget; 2017 Jul; 8(27):44994-45007. PubMed ID: 28402959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
    Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
    JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.